Exicure, Inc. Files Definitive Proxy Statement

Ticker: XCUR · Form: DEF 14A · Filed: Jul 30, 2024 · CIK: 1698530

Exicure, Inc. DEF 14A Filing Summary
FieldDetail
CompanyExicure, Inc. (XCUR)
Form TypeDEF 14A
Filed DateJul 30, 2024
Risk Levellow
Pages16
Reading Time20 min
Key Dollar Amounts$1.00, $1, $1.00 m
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, regulatory-filing, shareholder-meeting

Related Tickers: XCUR

TL;DR

Exicure (XCUR) proxy filing out, shareholders vote soon.

AI Summary

Exicure, Inc. filed a definitive proxy statement (DEF 14A) on July 30, 2024, for a special meeting of stockholders. The filing details information required for the proxy statement, including matters to be voted on by shareholders. Exicure, Inc. is a pharmaceutical preparations company incorporated in Delaware.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and voting matters for an upcoming special meeting, impacting corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information to shareholders about an upcoming meeting, not a filing that inherently introduces new financial risk.

Key Numbers

  • 2834 — SIC Code (Indicates Exicure operates in the Pharmaceutical Preparations industry.)

Key Players & Entities

  • EXICURE, INC. (company) — Registrant
  • 0001698530-24-000081 (filing_id) — Accession Number
  • 20240730 (date) — Filing Date
  • Max-1 Acquisition Corp (company) — Former Company Name

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with the information required for a definitive proxy statement concerning a special meeting of stockholders of Exicure, Inc.

When was this filing made?

This filing was made on July 30, 2024.

What is Exicure, Inc.'s industry?

Exicure, Inc. is in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.

What was Exicure, Inc. formerly known as?

Exicure, Inc. was formerly known as Max-1 Acquisition Corp, with a name change date of February 21, 2017.

Where is Exicure, Inc. incorporated?

Exicure, Inc. is incorporated in Delaware (DE).

Filing Stats: 4,904 words · 20 min read · ~16 pages · Grade level 12.7 · Accepted 2024-07-30 17:10:11

Key Financial Figures

  • $1.00 — st have a minimum bid price of at least $1.00 per share. If we are unable to meet the
  • $1 — ing the price of our common stock above $1.00, which is required for continued lis
  • $1.00 m — ither exceed or remain in excess of the $1.00 minimum bid price as required by Nasdaq,

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 11 HOUSEHOLDING OF PROXY MATERIALS 12 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING 13 OTHER MATTERS 14 PROXY CARD 15 Table of Contents ________________________________ PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 15, 2024 ________________________________ QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES Why am I receiving these materials We are providing you with these proxy materials because the Board of Directors (the "Board of Directors" or "Board") of Exicure, Inc. ("Exicure," the "Company," "we," "us" or "our") is soliciting your proxy to vote at a Special Meeting of Stockholders (the "Special Meeting"), including at any adjournments or postponements thereof. The Special Meeting will be held on Thursday, August 15, 2024, at 900 a.m. Central Time virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.comXCUR2024SM. T hese proxy materials are first being distributed or otherwise sent to stockholders on or about July 30, 2024. Why are you holding a virtual Special Meeting The Special Meeting will be held in a virtual meeting format only. We have designed our virtual format to enhance, rather than constrain, stockholder access, participation and communication. For example, the virtual format allows stockholders to communicate with us in advance of, and during, the Special Meeting so they can ask questions of our Board or management. Just as we did during our in-person meetings and this year's annual meeting, during the live QA session of the Special Meeting, we may answer questions as they come in and address those asked in advance, to the extent relevant to the business of the Special Meeting, as time permits. How do I attend the Special Meeting The Special Meeting is being held in a virtual-only format this year you cannot attend the Special Meeting physically. Stockholders att

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.